Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Should the medical device industry pay user fees to CMS?

September 27, 2017 By Heather Thompson

medical device industry user fees CMS

[Image with slight modifications courtesy of tara hunt on Flickr, per Creative Commons 2.0 license]

Achieving reimbursement from payers has become a major challenge for medical device companies. Could the solution lie in having them pay user fees to CMS – the way they do to FDA?

That was the question floated by Nadim Yared, president of CVRx and the current chairman of AdvaMed, during this week’s Medtech Conference powered by AdvaMed. Yared made the suggestion during a talk with Tamara Syrek Jensen, director of the coverage and analysis group at CMS, and Dr. Jeff Shuren, director of CDRH.

Yared focused on industry’s responsibility to ensure better predictability from payers. He discussed the evolution of MDUFMA, the user fee payment system with FDA that many have credited with a significant turn-around in the ability for medtech companies to get better access and measurable decision-making from CDRH.

“With MDUFMA, we fought it,” Yared noted. “We didn’t want to pay. And it took four iterations and 10 years to get it right.” But, he said, FDA took those resources and made changes to create a more inclusive and available FDA.

Although Yared stopped short of saying that user fees were the solution to a more collaborative relationship with CMS, there was an implication that industry should be charged to find a way to get the answers it wants (i.e. more transparency and predictability) from CMS and other payers.

“This is the right question for industry to ask,” said Mike Mussallem, CEO of Edwards Lifesciences, who moderated the panel. “Whether we should to go to Congress or think about other creative solutions, I don’t know, but industry certainly has a responsibility to help get payers to a place where we are working together.”

User fees could be one answer, Yared said. And Mussallem added the caveat that this is a brand new concept, and they had no idea what members would think.

“There could be other answers.” Yared laughed,” “It could be that Jeff is going to take some of his resources and share them with Tamara.”

He continued more seriously, “There is tremendous stress right now – the money is drying up.” He urged Jenkins to give feedback saying “We need quick success stories to engage with investors.“

A lot of ideas have been put on the table, added Shuren, to figure out what collectively makes sense.

The panel otherwise focused on how industry can better engage with CMS, “If you want presumptive payer decisions,” Jenkins said, “CMS and other payers have to be involved. They have to be in the room to have the conversation.”

Create your survey with SurveyMonkey

(Learn from some of the medical device industry’s top executives and experts at DeviceTalks Boston on Oct. 2.)

You may also like:

  • Big 100 largest medical device companies MDO
    The 10 largest medical device companies in the world
  • Money medical device startup medtech startups venture capital
    5 medtech funding insights you need to know
  • medical device manufacturing U.S.
    Why U.S. first may be the new medical device development…

Comments

  1. Chris Newmarker says

    October 3, 2017 at 3:50 pm

    We didn’t get a lot of responses to our survey, but what we received was interesting.

    “If we do this, I fear this will turn into a practice of ‘buying’ reimbursement.”
    – Sara Barbera, senior pricing manager at J&J

    “Bad idea – makes it look like manufacturers are paying for the right to play.”
    – Matthew Nowland, SVP of RA/QA at Mitra Biotech

Related Articles Read More >

iRhythm stays silent on federal grand jury subpoenas
iRhythm stock soars on Street-beating Q1
CMS
CMS extends joint replacement pricing by 3 years
DTW w MD
CMS expert Daubert sees “great improvement” in proposed rule

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech